Skip to content
2000
Volume 25, Issue 3
  • ISSN: 1871-5265
  • E-ISSN: 2212-3989

Abstract

The pink eye outbreak in 2023 was caused due to humid weather conditions in most regions of India. The most affected states include Delhi, Gujrat (21% cases), Maharashtra (30%), Himachal Pradesh (4%) and Karnataka (4%). The epidemiological data indicates that males have a high prevalence rate as compared to females; urban areas were most affected, and professionals as well as students were the population group that had the highest prevalence rate. The most common clinical manifestations were the presence of red eye, eye discharge, grittiness, and eyelashes being stuck together. One of the hallmarks of histopathology is a cobblestone formation of flattened nodules with central vascular centers. Conjunctivitis is a virus-mediated immune response accompanied by inflammation, which proceeds the immune reaction, giving rise to vasodilation, pseudo membrane formation, and conjunctivital discharge. The gold standard for the diagnosis of Conjunctivitis is the Adenoplus kit using PCR technology; apart from this slit lamp biomicroscope can be used for the evaluation. It is the need of the hour to spread awareness about the Pink Eye disease and the measures to prevent it.

Loading

Article metrics loading...

/content/journals/iddt/10.2174/0118715265291922240625054709
2024-07-19
2025-03-30
Loading full text...

Full text loading...

References

  1. AshiqueS. Sudden outbreak of conjunctivitis in the capital of India.Infect. Disord. Drug Targets2024244697110.2174/0118715265276248231205113605
    [Google Scholar]
  2. SenaratneT. GilbertC. Conjunctivitis.Community Eye Health200518537375 17491747
    [Google Scholar]
  3. IqbalT. AltafS. Overview of pink eye infection (Conjunctivitis).Biological Times20242127071
    [Google Scholar]
  4. HassanT.M. MajidB.T. Identification of common aerobic bacterial isolates among conjunctivitis in sulaymaniyah Province/Iraq.Iraqi J. Med. Sci.2018216
    [Google Scholar]
  5. Wikidoc: Conjunctivitis A historical perspective. Available from: https://www.wikidoc.org/index.php/Conjunctivitis_historical_perspective
  6. ZhangL. ZhaoN. ShaJ. Virology and epidemiology analyses of global adenovirus-associated conjunctivitis outbreaks, 1953–2013.Epidemiol. Infect.201614481661167210.1017/S0950268815003246 26732024
    [Google Scholar]
  7. MorganO.G. Conjunctivitis.SAGE Publications1931627685
    [Google Scholar]
  8. BalasopoulouA. KokkinosP. PagoulatosD. A molecular epidemiological analysis of adenoviruses from excess conjunctivitis cases.BMC Ophthalmol.20171715110.1186/s12886‑017‑0447‑x 28438142
    [Google Scholar]
  9. YunandaR. Genetic variation of adenoviruses causing conjunctivitis.Sriwij J Ophthalm202142909610.37275/sjo.v4i2.51
    [Google Scholar]
  10. MohanA. GajrajM. BansalE. VishnoiI. Pattern of presentation and laboratory findings of patients with epidemic keratoconjunctivitis in the 2023 outbreak in North India: A hospital-based analysis.J Clin Ophthalmol Res2024121293210.4103/jcor.jcor_133_23
    [Google Scholar]
  11. LindquistT.D. LindquistT.P. Conjunctivitis: an overview and classification Cornea.E-Book2021358
    [Google Scholar]
  12. AzariA.A. BarneyN.P. Conjunctivitis.JAMA2013310161721172910.1001/jama.2013.280318 24150468
    [Google Scholar]
  13. MutoT. ImaizumiS. KamoiK. Viral conjunctivitis.Viruses202315367610.3390/v15030676 36992385
    [Google Scholar]
  14. MahoneyM.J. BekibeleR. NotermannS.L. ReuterT.G. Borman-ShoapE.C. Pediatric Conjunctivitis: A review of clinical manifestations, diagnosis, and management.Children202310580810.3390/children10050808 37238356
    [Google Scholar]
  15. HoffmanJ. Adenovirus: ocular manifestations.Community Eye Health202033108737532395030
    [Google Scholar]
  16. MadurapandianY. RubeshkumarP. RajuM. Case report: An outbreak of viral conjunctivitis among the students and staff of visually impaired school, Tamil Nadu, India, 2020.Front. Public Health20221097820010.3389/fpubh.2022.978200 35991078
    [Google Scholar]
  17. DasA.V. BasuS. Epidemic keratoconjunctivitis in India: Electronic medical records-driven big data analytics report IV.Br. J. Ophthalmol.2022106333133510.1136/bjophthalmol‑2020‑317330 33229346
    [Google Scholar]
  18. BasuS. DasA.V. Epidemic keratoconjunctivitis in India: Trend analysis and implications for viral outbreaks.Indian J. Ophthalmol.202068573273610.4103/ijo.IJO_626_20 32317436
    [Google Scholar]
  19. MohapatraM. Earth System Science Organization [ESSO], Ministry of Earth Sciences [MoES]. India Meteorological Department, End of Season Report: Southwest Monsoon2023Available from: https://mausam.imd.gov.in/Forecast/marquee_data/Endofseasonreport_2023_30_9_2023.pdf2023
  20. SinghM.P. RamJ. KumarA. Molecular epidemiology of circulating human adenovirus types in acute conjunctivitis cases in Chandigarh, North India.Indian J. Med. Microbiol.201836111311510.4103/ijmm.IJMM_17_258 29735838
    [Google Scholar]
  21. GopalkrishnaV. GanorkarN.N. PatilP.R. Identification and molecular characterization of adenovirus types (HAdV‐8, HAdV‐37, HAdV‐4, HAdV‐3) in an epidemic of keratoconjunctivitis occurred in Pune, Maharashtra, Western India.J. Med. Virol.201688122100210510.1002/jmv.24565 27152842
    [Google Scholar]
  22. SundaramoorthyR. DhodapkarR. KaliaperumalS. HarishB.N. Outbreak of adenovirus serotype 8 keratoconjunctivitis in Puducherry, South India: A molecular epidemiological study.J. Infect. Dev. Ctries.201610444945210.3855/jidc.7225 27131013
    [Google Scholar]
  23. BeniwalN. ParvezR. SaharanB. MalikV. DhodapkarR. MuruganandamN. Adenoviral conjunctivitis in the andaman Islands: A clinical and molecular epidemiological study.Cureus20231512e5124110.7759/cureus.51241 38283502
    [Google Scholar]
  24. BanerjeeS. NathA. KumarH. Tackling the unprecedented rise in cases of conjunctivitis in Kolkata and Delhi, India.New Microbes New Infect.20235410117110.1016/j.nmni.2023.101171 37692290
    [Google Scholar]
  25. HaqA. WardakH. KraskianN. Infective conjunctivitis–its pathogenesis, management and complications.Common Eye Infections201321
    [Google Scholar]
  26. SinghR.B. LiuL. AnchoucheS. Ocular redness I: Etiology, pathogenesis, and assessment of conjunctival hyperemia.Ocul. Surf.20212113414410.1016/j.jtos.2021.05.003 34010701
    [Google Scholar]
  27. OmariA.A. MianS.I. Adenoviral keratitis.Curr. Opin. Ophthalmol.201829436537210.1097/ICU.0000000000000485 29708932
    [Google Scholar]
  28. ChigbuD.I. MinhasB.K. Immunopathology of Allergic Conjunctivitis.Eur. Med. J.20183768310.33590/emj/10312711
    [Google Scholar]
  29. RajaiyaJ. SahaA. ZhouX. ChodoshJ. Human adenovirus species D interactions with corneal stromal cells.Viruses20211312250510.3390/v13122505 34960773
    [Google Scholar]
  30. ChigbuD.I. KarbachN.J. AbuS.L. HeharN.K. Cytokines in allergic conjunctivitis: Unraveling their pathophysiological roles.Life202414335010.3390/life14030350 38541674
    [Google Scholar]
  31. Conjunctivitis cases swell to nearly 3.6 lakh across Maharashtra.Available from: https://m.timesofindia.com/city/mumbai/conjunctivitis-cases-swell-to-nearly-3-6-lakh-across-maharashtra/articleshow/102627172.cms
  32. IslamM.A. HossainM.I. BhattacharyaP. Adenovirus outbreak in India: Seeking solutions for child mortality.Int J Surgery: Global Heal202365e023910.1097/GH9.0000000000000239
    [Google Scholar]
  33. 2.17 L conjunctivitis cases.Available from: https://indianexpress.com/article/cities/baroda/2-17-l-conjunctivitis-cases-since-june-8873843/
  34. RohillaR. AgarwalR. MohantyA. Abu SerhanH. SahR. The never-seen upsurge of eye flu cases in India: One more menace due to a virus.Int. J. Surg. Open20235910067910.1016/j.ijso.2023.100679
    [Google Scholar]
  35. Conjunctivitis Cases Spike In Delhi-NCR, 100 Cases In AIIMS Daily.Available from: https://www.ndtv.com/delhi-news/conjunctivitis-cases-spike-in-delhi-ncr-100-cases-in-aiims-daily-4240243
  36. Saad AmjadS. MemonH. SoomroS.R. QamarM.A. AnjumM.U. HasanainM. Outbreak of conjunctivitis in South Asia: A landscape of current situation and rapid review of literature.Int J Clin Stud Med Case Rep2024392510.46998/IJCMCR.2024.39.000960
    [Google Scholar]
  37. Karnataka Recorded over 40,000 Cases of Conjunctivitis between July 25 - Aug 4th: Health Department Data. THE INDIAN EXPRESS.2024Available from: hhttps://indianexpress.com/article/cities/bangalore/karnataka-recorded-over-40000-cases-of-conjunctivitis-between-july-25-and-august-4-health-dept-data-8882675/#:~:text=Karnataka%20has%20recorded%2040%2C477%20cases,share%20the%20maximum%20caseload%2C%20respectively
  38. Ludhiana sees increase in conjunctivitis cases. The Tribune. Available from: https://www.tribuneindia.com/news/ludhiana/ludhiana-sees-increase-in-conjunctivitis-cases-530596
  39. 19,873 Conjunctivitis Cases In Chhattisgarh; Infected Children Told To Skip School.Available from: https://www.swachhindia.ndtv.com/19873-conjunctivitis-cases-in-chhattisgarh-infected-children-told-to-skip-school-80425/
  40. Over 38,000 conjunctivitis cases reported in Himachal Pradesh in August.Available from: https://economictimes.indiatimes.com/news/india/over-38000-conjunctivitis-cases-reported-in-himachal-pradesh-in-august/articleshow/103202680.cms?from=mdr
  41. AkhterM.H. AhmadI. AlshahraniM.Y. Drug delivery challenges and current progress in nanocarrier-based ocular therapeutic systems.Gels2022828210.3390/gels8020082 35200463
    [Google Scholar]
  42. JohnsonD. LiuD. SimelD. Does this patient with acute infectious Conjunctivitis have a bacterial infection?: The rational clinical examination systematic review.JAMA2022327222231223710.1001/jama.2022.7687 35699701
    [Google Scholar]
  43. FredrickN. NirmalS. KrishnasamyK. KarthikT. KumarN.K.S. SenthilvelanS. A clinical-virological study on identification of viral aetiological agents in Conjunctivitis.J Ophthalm Sci Res20236115156
    [Google Scholar]
  44. DoddikoppadP. ShenoyB. Adenovirus infections in paediatrics: Understanding the symptoms, diagnosis and treatment.Karnat Paed J20233915910.25259/KPJ_38_2023
    [Google Scholar]
  45. AfrasiabiV. GhojoghiR. HosseiniS.Y. The molecular epidemiology, genotyping, and clinical manifestation of prevalent adenovirus infection during the epidemic keratoconjunctivitis, South of Iran.Eur. J. Med. Res.202328110810.1186/s40001‑022‑00928‑0 36859343
    [Google Scholar]
  46. HashmiM.F. GurnaniB. BensonS. PriceK.L. Conjunctivitis.Treasure Island, FLStatPearls Publishing2024120
    [Google Scholar]
  47. Martín-MoroJ.G. Zarallo-GallardoJ. Guzmán-AlmagroE. RodríguezC.A. A systematic review and meta-analysis on the efficacy of topical povidone-iodine in adenoviral Conjunctivitis.Cont. Lens and Anterior Eye2023465101873
    [Google Scholar]
  48. KanaiK. WhitesideM. WongM. Case series: Unbiased deep sequencing analysis of acute infectious Conjunctivitis in an ambulatory eye center in Berkeley, California.Optom. Vis. Sci.2023100427628010.1097/OPX.0000000000002010 36880993
    [Google Scholar]
  49. IrfanS. Understanding adenoviral conjunctivitis.Acta Scient Ophthalmol2023612
    [Google Scholar]
  50. OdilovaG.R. KhudiyevaN.Y. Features of humoral immunity indicators in the blood serum of patients with adenoviral conjunctivitis before and after treatment.Cent Asian J Med20233225233
    [Google Scholar]
  51. SonawaneS.M. LohiyaG.V. RaoA.K. BeniwalM. ChavanS.U. AparadhV.M. Conjunctivitis in unusual populations: A review of rare cases and challenges in diagnosis and management.World J Adv ResRev202319313261336
    [Google Scholar]
  52. YeuE. HauswirthS. A review of the differential diagnosis of acute infectious conjunctivitis: Implications for treatment and management.Clin. Ophthalmol.20201480581310.2147/OPTH.S236571 32210533
    [Google Scholar]
  53. JasimH.Z. Al-JuboryM. Understanding conjunctivitis: Symptoms, causes, and treatment.Schol J Appl Med Sci202412325525810.36347/sjams.2024.v12i03.007
    [Google Scholar]
  54. ChanV.F. YongA.C. Azuara-BlancoA. A systematic review of clinical practice guidelines for infectious and non-infectious Conjunctivitis.Ophthalmic Epidemiol.202229547348210.1080/09286586.2021.1971262 34459321
    [Google Scholar]
  55. PenzaK.S. MurrayM.A. MyersJ.F. MaxsonJ. FurstJ.W. PecinaJ.L. Treating pediatric conjunctivitis without an exam: An evaluation of outcomes and antibiotic usage.J. Telemed. Telecare2020261-2737810.1177/1357633X18793031 30153768
    [Google Scholar]
  56. MiyazakiD. TakamuraE. UchioE. Japanese guidelines for allergic conjunctival diseases 2020.Allergol. Int.202069334635510.1016/j.alit.2020.03.005 33211650
    [Google Scholar]
  57. PetrilloF. PetrilloA. SassoF.P. SchettinoA. MaioneA. GaldieroM. Viral infection and antiviral treatments in ocular pathologies.Microorganisms20221011222410.3390/microorganisms10112224 36363815
    [Google Scholar]
  58. HollandE.J. FingeretM. MahF.S. Use of topical steroids in Conjunctivitis: A review of the evidence.Cornea20193881062106710.1097/ICO.0000000000001982 31276464
    [Google Scholar]
  59. LiuS.H. HawkinsB.S. RenM. Topical pharmacologic interventions versus active control, placebo, or no treatment for epidemic keratoconjunctivitis: Findings from a Cochrane systematic review.Am. J. Ophthalmol.202224026527510.1016/j.ajo.2022.03.018 35331686
    [Google Scholar]
  60. TsuiE. SellaR. ThamV. Pathogen surveillance for acute infectious conjunctivitis.JAMA Ophthalmol.2023141121140114410.1001/jamaophthalmol.2023.4785 37917077
    [Google Scholar]
  61. KuoI.C. GowerE.W. Cost savings from a policy to diagnose and prevent transmission of adenoviral Conjunctivitis in employees of a large academic medical center.JAMA Ophthalmol.2021139551852410.1001/jamaophthalmol.2021.0150 33792644
    [Google Scholar]
  62. JonasR.A. UngL. RajaiyaJ. ChodoshJ. Mystery eye: Human adenovirus and the enigma of epidemic keratoconjunctivitis.Prog. Retin. Eye Res.20207610082610.1016/j.preteyeres.2019.100826 31891773
    [Google Scholar]
  63. VaziraniJ. Commentary: Adenoviral keratoconjunctivitis—Seasonal trends and influence of environmental factors.Indian J. Ophthalmol.202068573673710.4103/ijo.IJO_862_20 32317437
    [Google Scholar]
  64. Van GelderR.N. AkileswaranL. NakamichiK. StromanD. Molecular and clinical characterization of human adenovirus e4–associated conjunctivitis.Am. J. Ophthalmol.202223322724210.1016/j.ajo.2021.10.028 34740631
    [Google Scholar]
  65. MiroE. Del CuerpoM. RubioM. Whole‐genome analysis to describe a human adenovirus D8 conjunctivitis outbreak in a tertiary hospital.J. Med. Virol.20219384840484510.1002/jmv.26850 33543795
    [Google Scholar]
  66. NguyenT.T.H. LeT.A. NguyenV.H. Molecular typing of conjunctivitis‐causing adenoviruses in Hanoi, Vietnam from 2017 to 2019 and complete genome analysis of the most prevalent type (HAdV‐8).J. Med. Virol.202092123100311010.1002/jmv.25844 32266999
    [Google Scholar]
  67. NakamichiK. AkileswaranL. MeirickT. Machine learning prediction of adenovirus D8 conjunctivitis complications from viral whole-genome sequence.Ophthalmol. Sci.20222410016610.1016/j.xops.2022.100166 36531578
    [Google Scholar]
  68. LynchJ.P.III KajonA.E. Adenovirus: Epidemiology, global spread of novel types, and approach to treatment.Semin. Respir. Crit. Care Med.2021426800821
    [Google Scholar]
  69. Lavista FerresJ.M. MeirickT. LomazowW. LeeC.S. LeeA.Y. LeeM.D. Association of public health measures during the COVID-19 pandemic with the incidence of infectious Conjunctivitis.JAMA Ophthalmol.20221401434910.1001/jamaophthalmol.2021.4852 34792555
    [Google Scholar]
  70. KaurG. SeitzmanG.D. LietmanT.M. Keeping an eye on pink eye: A global conjunctivitis outbreak expert survey.Int. Health202214554254410.1093/inthealth/ihab049 34409991
    [Google Scholar]
  71. Di ZazzoA. YangW. CoassinM. Signaling lipids as diagnostic biomarkers for ocular surface cicatrizing conjunctivitis.J. Mol. Med. (Berl.)202098575176010.1007/s00109‑020‑01907‑w 32313985
    [Google Scholar]
  72. SavchenkoT. DegtyaryovE. RadzyukevichY. BuryakV. Therapeutic potential of plant oxylipins.Int. J. Mol. Sci.202223231462710.3390/ijms232314627 36498955
    [Google Scholar]
  73. PolatHK KurtN AytekinE Bozdağ PehlivanS ÇalışS Novel drug delivery systems to improve the treatment of keratitis. J Ocul Pharmacol Ther2022386jop.2021.012710.1089/jop.2021.0127 35763406
    [Google Scholar]
  74. HanH. LiS. XuM. Polymer- and lipid-based nanocarriers for ocular drug delivery: Current status and future perspectives.Adv. Drug Deliv. Rev.202319611477010.1016/j.addr.2023.114770 36894134
    [Google Scholar]
  75. YoussefA.A.A. DudhipalaN. MajumdarS. Dual drug loaded lipid nanocarrier formulations for topical ocular applications.Int. J. Nanomedicine2022172283229910.2147/IJN.S360740 35611213
    [Google Scholar]
  76. AielloF. Gallo AfflittoG. LiJ.P.O. MartucciA. CesareoM. NucciC. CannabinEYEds: The endocannabinoid system as a regulator of the ocular surface nociception, inflammatory response, neovascularization, and wound healing.J. Clin. Med.2020912403610.3390/jcm9124036 33327429
    [Google Scholar]
  77. TandonR. VashistP. GuptaN. Association of dry eye disease and sun exposure in geographically diverse adult (≥40 years) populations of India: The SEED (sun exposure, environment and dry eye disease) study: Second report of the ICMR-EYE SEE study group.Ocul. Surf.202018471873010.1016/j.jtos.2020.07.016 32783926
    [Google Scholar]
  78. SinghH. NielsenM. GreatrexH. Causes, impacts, and mitigation strategies of urban pluvial floods in India: A systematic review.Int. J. Disaster Risk Reduct.20239310375110.1016/j.ijdrr.2023.103751
    [Google Scholar]
  79. Lalthazuali BhanS. Post flood vector-borne disease surveillance: An experience from Malappuram district of Kerala, India in 2018. Int JMosq Res 202075016
    [Google Scholar]
/content/journals/iddt/10.2174/0118715265291922240625054709
Loading
/content/journals/iddt/10.2174/0118715265291922240625054709
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test